Screening method and system for key molecules influencing medical outcome variables, terminal and storage medium
A screening method and outcome technology, applied in the field of high-throughput sequencing, can solve problems such as non-occurrence, and achieve the effect of improving the efficiency of clinical transformation and solving instability and poor repeatability.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0060] Example 1 Screening of long non-coding RNAs that have a significant and stable impact on the disease-free survival time of patients with cholangiocarcinoma
[0061] Taking COX proportional hazards regression as an example, 927 long-chain non-coding RNAs that were significantly highly expressed in cholangiocarcinoma tissues were screened from 61 cholangiocarcinoma transcriptome sequencing samples. Behavioral gene name, listed as the sample name, and the matrix is the expression level of the gene in the sample), to screen for long-chain non-coding RNA (ie, key molecules) that have a significant and stable effect on the disease-free survival time of patients with cholangiocarcinoma.
[0062] Executable program codes are stored in the memory of a certain intelligent terminal, and the processor of the intelligent terminal reads the executable program codes stored in the memory to execute the following key molecules affecting outcome variables in medicine (i.e. long-chain no...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com